Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Endo Pharmaceuticals Recalls Endocet Bottles With Wrong Pill Sizes
Endo Pharmaceuticals has issued a consumer level recall of two lots of Endocet 10 mg/325 mg tablets because these lots may contain incorrect tablets that have a higher dose of acetaminophen. Endocet 10 mg/325 mg is a combination product of two medications: oxycodone and acetaminophen. Endocet 10 mg/325 mg lot numbers 402415NV and #402426NV are being recalled because some bottles in these lots were found to contain Endocet 10 mg/650 mg tablets. Accidentally taking tablets with higher amounts of acetaminophen may result in liver toxicity. This voluntary recall is being made with the knowledge of the U.S. Food and Drug Administration (FDA). This recall only involves the two lots of Endocet 10 mg/325 mg. Oxycet, Percocet, Roxicet, Roxilox, Tylox, and other generic products of oxycodone/acetaminophen are not involved in this recall. For more information, please visit: phx.corporate-ir.net/phoenix.zhtml?c=231492&p=irol-newsArticle&ID=1579738&highlight=
Learn More

Rugby Recalls Children's Pain & Fever Concentrated Drops Due To Problems With Child-Resistant Closure
The U.S. Consumer Product Safety Commission (CPSC), Rugby Laboratories, Inc., and Altaire Pharmaceuticals, Inc., announced a recall of Children's Pain & Fever Concentrated Drops because of a failure to meet child-resistant closure requirements. Children's Pain & Fever Concentrated Drops contain acetaminophen and require child-resistant packaging by the Poison Prevention Packaging Act. For these recalled drops, the original bottle had child-resistant packaging, but a separate dropper unit provided for drug dispensing did not. This enables children to access the medicine and poses the risk for serious health problems or death if too much is consumed. The recalled Rugby Children's Pain & Fever Concentrated Drops (Acetaminophen Drops) come in a .5 fl. Oz. container. The lot numbers are 09002, 09379, 10272, 10368, 10487, 09131, 09394, 10273, 10406, 11058, 09215, 10154, 10366, and 10433. Affected lot numbers can be found stamped on the bottom of the carton with the expiration date, or it can be found above the label on the bottle printed in black. The drops were sold at drug stores, grocery stores and other retailers nationwide between January 2009 and June 2011. For more information, please visit: http://www.cpsc.gov/cpscpub/prerel/prhtml11/11258.html?tab=recalls
Learn More

Date Published Title Drug Source
2011-06-27 Endo Pharmaceuticals Recalls Endocet Bottles With Wrong Pill Sizes Acetaminophen with Oxycodone Manufacturer
2011-06-27 Rugby Recalls Children's Pain & Fever Concentrated Drops Due To Problems With Child-Resistant Closure Acetaminophen Manufacturer
2011-06-24 FDA Modifies Dosing Recommendations for Erythropoiesis-Stimulating Agents Epoetin Alfa FDA
2011-06-24 New Study: Combining Commonly Used Drugs Linked to a Greater Risk of Death and Declining Brain Function Beclomethasone MediGuard CRT
2011-06-23 New Study Suggests High-Dose Statins May Cause Diabetes Atorvastatin MediGuard CRT
2011-06-18 Ortho-McNeil Voluntarily Recalls Two Lots: Risperdal (Risperidone) 3mg and Risperidone 2mg Risperidone Manufacturer
2011-06-16 FDA Warns: Chantix (varenicline) May Increase the Risk of Heart Attack, Angina and Other Heart-Related Adverse Events in Patients with Cardiovascular Disease Varenicline FDA
2011-06-15 FDA Issues Safety Update for Ongoing Safety Review of Actos (Pioglitazone) and Increased Risk of Bladder Cancer Glimepiride and Pioglitazone FDA
2011-06-15 Bristol-Myers Squibb Expands May 2011 Recall: More Tablet Strengths Recalled Warfarin Manufacturer
2011-06-14 Endo Pharmaceuticals Recalls Single Lot of Percocet 10 mg/325 mg Acetaminophen with Oxycodone FDA
2011-06-14 FDA Issues Warning About Medication Errors Due to Name Confusion Between Risperidone (Risperdal) and Ropinirole (Requip) Risperidone FDA
2011-06-13 Healthcare Providers Reminded About Risks With Victoza Liraglutide FDA
2011-06-09 FDA Issues Drug Safety Communication: Finasteride (Proscar, Propecia), Dutasteride (Avodart, Jalyn) May Increase the Risk of a More Serious Form of Prostate Cancer Finasteride FDA
2011-06-08 FDA Limits Use of 80 mg Simvastatin Simvastatin FDA
2011-06-06 Lupin Pharmaceuticals Inc. Recalls Several Lots of Perindopril 2 mg Tablets Perindopril FDA
2011-06-02 FDA Completes Safety Review: Angiotensin Receptor Blockers (ARBs) for High Blood Pressure Do Not Increase Risk of Cancer Telmisartan FDA
2011-06-01 Sandoz Inc. Recalls Single Lot of Metformin Hydrochloride Tablets 1000 mg Metformin FDA
2011-06-01 Teva Pharmaceuticals Recalls Single Lot of Lansoprazole Delayed-Release Capsules USP, 30 mg Lansoprazole FDA
2011-06-01 Teva Pharmaceuticals USA Recalls Single Lot of Nabumetone Tablets USP, 750 mg Nabumetone FDA
2011-06-01 Pentrexyl Forte Natural Recalled Due to Misleading Packaging Ampicillin FDA